| Neuraxpharm Switzerland AG - Tranxilium 50 mg, Filmtabletten | | 45388 | | 01 | | Tranxilium 50 mg | | Filmtabletten | | N05BA05 | | Potassium Clorazepate | | 03.04.1984 | | |
| | Composition | | dikalii clorazepas 50 mg, E 127, lactosum 52.88 mg, magnesii stearas, talcum, kalii carbonas, kalii chloridum, magnesii oxidum leve, polacrilinum kalicum, ricini oleum hydrogenatum, Überzug: copolymerum methacrylatis butylati basicum, diethylis phthalas, E 127, E 171, talcum pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Dipotassic Clorazepate | 50 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | | Überzug | | | | | | | | color. | | | | color. | | Potassium Carbonate | | | | Potassium Chloride | | | | | 52.88 mg | | | Light Magnesium Oxide | | | | | | | | | | | | | | | | Talcum | | | | | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 050 | 30 Tablet(s) | PR | PR | B | | No |
|
|
